We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-18.02%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$562M
AUM Growth
-$160M
Cap. Flow
-$4.98M
Cap. Flow %
-0.89%
Top 10 Hldgs %
14.44%
Holding
319
New
49
Increased
97
Reduced
64
Closed
52

Top Buys

Rank Stock Value
1
NET icon
Cloudflare
NET
+$9.55M
2
S icon
SentinelOne
S
+$8.48M
3
OKTA icon
Okta
OKTA
+$8M
4
GTLB icon
GitLab
GTLB
+$7.83M
5
CFLT
Confluent
CFLT
+$6.55M

Top Sells

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$14.5M
2
GTM
ZoomInfo Technologies
GTM
+$11.2M
3
DT icon
Dynatrace
DT
+$10.6M
4
HUBS icon
HubSpot
HUBS
+$9.63M
5
ESTC icon
Elastic
ESTC
+$9.08M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Industrials 11.44%
3 Healthcare 8.57%
4 Financials 7.36%
5 Communication Services 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMP icon
126
LiveRamp
RAMP
$2.3B
$1.04M 0.19%
40,343
+708
+2% +$21K
NVDA icon
127
NVIDIA
NVDA
$4.92T
$988K 0.18%
65,150
-310
-0.5% -$5.85K
CSTL icon
128
Castle Biosciences
CSTL
$725M
$963K 0.17%
43,875
+3,659
+9% +$85K
DCT
129
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$947K 0.17%
63,748
+3,673
+6% +$64.5K
ADPT icon
130
Adaptive Biotechnologies
ADPT
$3.5B
$929K 0.17%
114,780
+8,288
+8% +$72.9K
QTRX icon
131
Quanterix
QTRX
$184M
$927K 0.16%
57,249
+675
+1% +$13.9K
QTWO icon
132
Q2 Holdings
QTWO
$3.48B
$876K 0.16%
22,704
+2,184
+11% +$106K
CVS icon
133
CVS Health
CVS
$137B
$633K 0.11%
6,833
SNPS icon
134
Synopsys
SNPS
$72.5B
$610K 0.11%
2,010
BAC icon
135
Bank of America
BAC
$424B
$598K 0.11%
19,201
+33
+0.2% +$1.19K
ELV icon
136
Elevance Health
ELV
$82.9B
$546K 0.1%
1,132
-229
-17% -$113K
INTU icon
137
Intuit
INTU
$80.4B
$543K 0.1%
1,408
-2
-0.1% -$828
EGRX
138
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$533K 0.09%
12,000
-12,000
-50% -$551K
PG icon
139
Procter & Gamble
PG
$347B
$527K 0.09%
3,664
-398
-10% -$59.8K
JPM icon
140
JPMorgan Chase
JPM
$901B
$453K 0.08%
4,021
-1,827
-31% -$226K
MSCI icon
141
MSCI
MSCI
$45.5B
$448K 0.08%
1,086
BMY icon
142
Bristol-Myers Squibb
BMY
$123B
$409K 0.07%
+5,318
New +$405K
IJH icon
143
iShares Core S&P Mid-Cap ETF
IJH
$121B
$395K 0.07%
8,735
+90
+1% +$4.44K
PEP icon
144
PepsiCo
PEP
$185B
$395K 0.07%
2,373
-604
-20% -$102K
META icon
145
Meta Platforms (Facebook)
META
$1.64T
$350K 0.06%
+2,173
New +$419K
ZTS icon
146
Zoetis
ZTS
$31.9B
$347K 0.06%
+2,020
New +$349K
APD icon
147
Air Products & Chemicals
APD
$66.1B
$319K 0.06%
1,328
-214
-14% -$52K
KO icon
148
Coca-Cola
KO
$353B
$315K 0.06%
5,000
VEA icon
149
Vanguard FTSE Developed Markets ETF
VEA
$224B
$293K 0.05%
7,192
+141
+2% +$6.27K
MRSH
150
Marsh
MRSH
$87.7B
$284K 0.05%
1,831
-517
-22% -$82.9K

Similar funds

Stanley-Laman Group's Q2 2022 Portfolio in Review

As of Q2 2022, Stanley-Laman Group held 319 positions worth $562M, down 22% from $722M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Stanley-Laman Group's Q2 2022 filing shows 49 new, 97 increased, 64 reduced and 52 closed positions. Its largest new stake was Cloudflare: 132,651 shares worth $5.8M. The largest sale was FIVE9, an estimated $14.5M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 37% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2022 buy was Cloudflare: 132,651 shares worth $5.8M.
  • Stanley-Laman Group added most to Blackstone in Q2 2022, an estimated $3.36M increase.
  • Stanley-Laman Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $1.44M.
  • Stanley-Laman Group fully exited FIVE9 in Q2 2022, selling an estimated $14.5M.
  • Stanley-Laman Group's ten largest holdings make up 14% of its $562M portfolio in Q2 2022.
  • Stanley-Laman Group opened 49 new positions and closed 52 in Q2 2022.
  • Stanley-Laman Group's portfolio value fell 22% quarter-over-quarter to $562M.

Based on Stanley-Laman Group's 13F filing for Q2 2022, filed 8 Aug 2022.